FDA Inspection 1248443 — Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd
The FDA completed an inspection of Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd on Aug 9, 2024 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 9, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)